Marco L. Ernst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marco L. Ernst has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- David Baker
Institute for Protein Design, University of Washington, Seattle, WA, USA
2 shared publications - Dongping Chen
University of Basel
2 shared publications Elinor Morris
Department of Chemistry, University of Basel, Basel, Switzerland
2 shared publicationsKailin Zhang
Department of Chemistry, University of Basel, Basel, Switzerland
2 shared publications- Thomas R. Ward
University of Basel
2 shared publications - Xiang Zhang
University of Basel
2 shared publications
Latest Publications
- 17 October 2026
- Published by Elsevier in Trends in Biochemical Sciences
Enzyme proximity sequencing: mapping multidimensional enzyme fitness at scale
- 17 October 2026
- Published by Elsevier in Trends in Biochemical Sciences
Enzyme proximity sequencing: mapping multidimensional enzyme fitness at scale
- Open Access
- 3 November 2025
- Published by Springer Nature in Nature Catalysis
- Vol. 8 (11) , 1208-1219
De novo design and evolution of an artificial metathase for cytoplasmic olefin metathesis
Artificial metalloenzymes present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Here we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis—for whole-cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo-designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (turnover number ≥1,000) and biocompatibility. This work represents a pronounced leap in the de novo design and in cellulo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.
- 3 November 2025
- Published by Springer Nature in Nature Catalysis
- Vol. 8 (11) , 1208-1219
Open AccessDe novo design and evolution of an artificial metathase for cytoplasmic olefin metathesis
Artificial metalloenzymes present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Here we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis—for whole-cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo-designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (turnover number ≥1,000) and biocompatibility. This work represents a pronounced leap in the de novo design and in cellulo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.
- Open Access
- 13 February 2025
- Published by Springer Nature in Research Square
De Novo Design and Evolution of an Artificial Metathase for Cytoplasmic Olefin Metathesis
Artificial metalloenzymes (ArMs) present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Herein, we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis (RCM)— for whole cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (TON ≥ 1000) and biocompatibility. This work represents a pronounced leap in the de novo design and in vivo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.
- 13 February 2025
- Published by Springer Nature in Research Square
Open AccessDe Novo Design and Evolution of an Artificial Metathase for Cytoplasmic Olefin Metathesis
Artificial metalloenzymes (ArMs) present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Herein, we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis (RCM)— for whole cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (TON ≥ 1000) and biocompatibility. This work represents a pronounced leap in the de novo design and in vivo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.